Who owns PHVS
110 institutions reported holding PHVS for 2026Q1, more than the 106 a quarter earlier.
110
Institutions reporting a position · as of 2026Q1 · up from 106 the quarter before
- Shares held by institutions
- 58.9M
Shares held by institutions · long US equity positions only, as reported on Form 13F
- Reported value
- $1.66B
Reported value · at 2026-03-31 prices, not today's
- Opened vs closed
- 9 / 6
Opened vs closed · new positions against positions exited in the latest quarter
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 21
- New positions
- 9
- Positions exited
- 6
- Added to
- 35
- Reduced
- 35
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 110 | 58.9M | $1.66B |
| 2025Q4 | 106 | 59.0M | $1.64B |
| 2025Q3 | 83 | 57.8M | $1.44B |
| 2025Q2 | 60 | 45.0M | $793M |
| 2025Q1 | 52 | 44.9M | $706M |
| 2024Q4 | 54 | 44.6M | $856M |
| 2024Q3 | 51 | 45.0M | $834M |
| 2024Q2 | 36 | 43.0M | $809M |
| 2024Q1 | 35 | 42.4M | $980M |
| 2023Q4 | 36 | 40.7M | $1.14B |
| 2023Q3 | 21 | 29.1M | $607M |
| 2023Q2 | 21 | 28.9M | $442M |
| 2023Q1 | 21 | 21.8M | $174M |
| 2022Q4 | 25 | 21.3M | $240M |
| 2022Q3 | 21 | 22.3M | $174M |
| 2022Q2 | 20 | 22.4M | $494M |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| GENERAL ATLANTIC, L.P. | 8.0M | n/a | $227M |
| FMR LLC | 6.3M | n/a | $178M |
| Foresite Capital Management IV, LLC | 4.8M | n/a | $135M |
| venBio Partners LLC | 4.6M | n/a | $131M |
| VIKING GLOBAL INVESTORS LP | 3.7M | n/a | $103M |
| EQT Fund Management S.a r.l. | 3.4M | n/a | $97M |
| DEERFIELD MANAGEMENT CO /NY | 3.1M | n/a | $88M |
| Bain Capital Life Sciences Investors, LLC | 2.7M | n/a | $76M |
| WELLINGTON MANAGEMENT GROUP LLP | 2.1M | n/a | $60M |
| Commodore Capital LP | 1.9M | n/a | $54M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…